BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24679215)

  • 1. Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation.
    Wang Y; Latypov RF; Lomakin A; Meyer JA; Kerwin BA; Vunnum S; Benedek GB
    Mol Pharm; 2014 May; 11(5):1391-402. PubMed ID: 24679215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-liquid phase transition of protein aqueous solutions isothermally induced by protein cross-linking.
    Wang Y; Annunziata O
    Langmuir; 2008 Mar; 24(6):2799-807. PubMed ID: 18229962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between protein-polyethylene glycol (PEG) interactions and the effect of PEG on protein-protein interactions using the liquid-liquid phase transition.
    Wang Y; Annunziata O
    J Phys Chem B; 2007 Feb; 111(5):1222-30. PubMed ID: 17266278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effects of pH and ionic strength on colloidal stability of IgG solutions by PEG-induced liquid-liquid phase separation.
    Thompson RW; Latypov RF; Wang Y; Lomakin A; Meyer JA; Vunnum S; Benedek GB
    J Chem Phys; 2016 Nov; 145(18):185101. PubMed ID: 27846698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 May; 13(5):1431-44. PubMed ID: 27017836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polyethylene glycol on the liquid-liquid phase transition in aqueous protein solutions.
    Annunziata O; Asherie N; Lomakin A; Pande J; Ogun O; Benedek GB
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14165-70. PubMed ID: 12391331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual Variable Domain Immunoglobulin Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 Mar; 13(3):774-83. PubMed ID: 26756795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-Liquid Phase Separation in a Dual Variable Domain Immunoglobulin Protein Solution: Effect of Formulation Factors and Protein-Protein Interactions.
    Raut AS; Kalonia DS
    Mol Pharm; 2015 Sep; 12(9):3261-71. PubMed ID: 26237070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization of IgG1 by mapping its liquid-liquid phase separation curves.
    Jion AI; Goh LT; Oh SK
    Biotechnol Bioeng; 2006 Dec; 95(5):911-8. PubMed ID: 16804945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.
    Meza NP; Hardy CA; Morin KH; Huang C; Raghava S; Song J; Zhang J; Wang Y
    Mol Pharm; 2023 Nov; 20(11):5842-5855. PubMed ID: 37867303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Evaluation of Protein Solubility in Aqueous Solutions by PEG-Induced Liquid-Liquid Phase Separation.
    Wang Y; Latypov RF
    Methods Mol Biol; 2019; 2039():39-49. PubMed ID: 31342417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure.
    Chow CK; Allan BW; Chai Q; Atwell S; Lu J
    Mol Pharm; 2016 Mar; 13(3):915-23. PubMed ID: 26849155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-Liquid Phase Separations in Urate Oxidase/PEG Mixtures: Characterization and Implications for Protein Crystallization.
    Vivarès D; Bonneté F
    J Phys Chem B; 2004 May; 108(20):6498-507. PubMed ID: 18950139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.
    Bramham JE; Davies SA; Podmore A; Golovanov AP
    MAbs; 2021; 13(1):1940666. PubMed ID: 34225583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Aggregation and Nucleation Mechanism of the Monoclonal Antibody Anti-CD20 Near Liquid-Liquid Phase Separation (LLPS).
    Pantuso E; Mastropietro TF; Briuglia ML; Gerard CJJ; Curcio E; Ter Horst JH; Nicoletta FP; Di Profio G
    Sci Rep; 2020 Jun; 10(1):8902. PubMed ID: 32483267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of PEG-induced precipitation with protein-protein interactions and aggregation rates of high concentration mAb formulations at 5 °C.
    Wälchli R; Fanizzi F; Massant J; Arosio P
    Eur J Pharm Biopharm; 2020 Jun; 151():53-60. PubMed ID: 32197816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.
    Indulkar AS; Box KJ; Taylor R; Ruiz R; Taylor LS
    Mol Pharm; 2015 Jul; 12(7):2365-77. PubMed ID: 25984769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observation of liquid-liquid phase separation for eye lens gammaS-crystallin.
    Annunziata O; Ogun O; Benedek GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):970-4. PubMed ID: 12529503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir.
    Ilevbare GA; Liu H; Pereira J; Edgar KJ; Taylor LS
    Mol Pharm; 2013 Sep; 10(9):3392-403. PubMed ID: 23829687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.